What is Natalist?
Natalist operates at the intersection of consumer health and reproductive wellness, offering a comprehensive suite of fertility and pregnancy essentials. The company's product portfolio, which includes supplements, diagnostic tests, and prenatal vitamins, is meticulously designed to support users through every stage of conception and parenthood. Founded by mothers, the brand distinguishes itself through a commitment to high-quality ingredients and environmental sustainability.
Beyond its product offerings, Natalist has integrated a convenient, subscription-based shopping model that addresses the logistical challenges often faced by those planning to conceive. By prioritizing both efficacy and eco-conscious practices, the company has carved out a unique niche, effectively bridging the gap between clinical necessity and consumer-friendly self-care.
How much funding has Natalist raised?
Natalist has raised a total of $5M across 1 funding round:
Angel/Seed
$5M
Angel/Seed (2019): $5M with participation from Julia Cheek, xFund, Katrina Lake, Cowboy Ventures, Fuel Capital, RockHealth, Collaborative Fund, and Christine Lemke
Key Investors in Natalist
Fuel Capital
A professional technology-focused private equity firm specializing in growth-stage companies and mid-cap buyouts across sectors including medical technology and advanced manufacturing.
Collaborative Fund
A leading source of capital and strategic support for entrepreneurs, with a portfolio that includes high-impact companies in the consumer and health sectors.
Cowboy Ventures
A venture capital firm focused on early-stage investments, providing the necessary resources for startups to scale and achieve market leadership.
What's next for Natalist?
Looking ahead, the strategic deployment of this capital will likely focus on accelerating product innovation and optimizing the company's supply chain to meet growing demand. As Natalist transitions from its initial development phase into a more mature enterprise-level operation, the focus will shift toward scaling its digital infrastructure and expanding its market footprint. The backing from seasoned venture firms suggests a long-term commitment to establishing Natalist as a dominant player in the reproductive health space.
Future growth initiatives are expected to include the diversification of the product line and the potential exploration of new service-oriented offerings. By maintaining its core values of transparency and sustainability, Natalist is poised to navigate the complexities of the health-tech landscape while continuing to provide essential support to its expanding customer base.
